Teva Pharmaceutical Industries Limited · TASE:TEVA

Teva Pharmaceutical Industries — Investor Presentation (June 2014)

13 slides from Teva Pharmaceutical Industries's investor presentation, Jun 9, 2014

  1. Slide 1: Climbing against MS

    Climbing against MS Mont Ventoux, France, June 9th 2014

  2. Slide 2: Mont Ventoux....1.600 altitude meters..

    Mont Ventoux....1.600 altitude meters.. Mont Ventoux, height 1.912 meter, base to peak approx. 1.600 meters • Can be climbed from three sides, Malaucene, Bedoin en Sault • Several nicknames: The Bald Mountain, The Giant of the Provence • Due to the extreme climate the peak of the mountain is bald

  3. Slide 3: ..the characteristic bald mountain....

    ..the characteristic bald mountain....

  4. Slide 4: Climbing against MS started in 2011....

    Climbing against MS started in 2011.... • 3 June 2011 • 16 participants • €10.000 raised

  5. Slide 5: ....grew in 2012…

    ....grew in 2012… • 18 May 2012 • 36 participants • More than €61.000 raised

  6. Slide 6: Teva and Klimmen tegen MS

    Teva and Klimmen tegen MS • In 2013 105 participants represented Teva • Total contribution: €80,000 of €500,000 • All participants reached the top • A team of 8 cyclists rode 1200 km from the Netherlands (Klimmen) to Mont Ventoux • In 2014 Teva will be main sponsor and contribute large delegation of

  7. Slide 7: On Mont Ventoux

    On Mont Ventoux ar tg 15 km | 9.1% sur tkm jal. 630m|

  8. Slide 8: On Mont Ventoux 2

    On Mont Ventoux 2

  9. Slide 9: END,

    END, P22 0F axMoZVENTOUX

  10. Slide 10: Klimmen tegen MS in 2014....

    Klimmen tegen MS in • June 9th 2014 2014.... • Sportive challenge • 1, 2 or 3 times Mont Ventoux • By bicycle, running or walking? • Financial challenge • Each participant to raise at least €500 • All proceeds will be used for MS research • Approx. 500 participants, >100 represent Teva!

  11. Slide 11: ....main sponsors

    ....Nain Sponsors | FUTURUMSHOP SPORT IS OUR PASSION LOS AL Wegéon Wast@pint ‘biogen idec_ afvalbeheer |

  12. Slide 12: Multiple Sclerose

    Multiple Sclerose MS is the most frequent disabling disease among young people in Europe Multiple Sclerosis is causes inflammations in the central nervous system 1 in 1.000 suffer from MS Not one person has the same form and symptoms Therefore, many persons with MS are not understood by people aroun

  13. Slide 13: Website and Social media - Dutch

    Website and Social media - Dutch • Website www.klimmentegenms.nl (English pages will be added)

Teva Pharmaceutical Industries — Investor Presentation (June 2014) on 6ix